Effects of LY450139, on the Progression of Alzheimer's Disease as Compared With Placebo
Clinical trial NCT00762411 · COMPLETED
Trial details
- NCT number
- NCT00762411
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-09-01
- Primary completion
- 2011-04-01
- Enrollment
- 1111
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.